|
1.
|
Geeraerts B and Tack J: Functional
dyspepsia: past, present, and future. J Gastroenterol. 43:251–255.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Mahadeva S and Goh KL: Epidemiology of
functional dyspepsia: a global perspective. World J Gastroenterol.
12:2661–2666. 2006.PubMed/NCBI
|
|
3.
|
Talley NJ, Weaver AL and Zinsmeister AR:
Impact of functional dyspepsia on quality of life. Dig Dis Sci.
40:584–589. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Chang L: Review article: epidemiology and
quality of life in functional gastrointestinal disorders. Aliment
Pharmacol Ther. 7:31–39. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Talley NJ: Functional gastrointestinal
disorders as a public health problem. Neurogastroenterol Motil.
1:121–129. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Powell N, Walker MM and Talley NJ:
Gastrointestinal eosinophils in health, disease and functional
disorders. Nat Rev Gastroenterol Hepatol. 7:146–156. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Speirs RS, Speirs EE and Ponzio NM: A role
for eosinophils in adaptive humoral immunity. Open Immunol J.
2:168–186. 2009. View Article : Google Scholar
|
|
8.
|
Stanghellini V, Tosetti C, Paternico A,
Barbara G, Morselli-Labate AM, Monetti N, Marengo M and Corinaldesi
R: Risk indicators of delayed gastric emptying of solids in
patients with functional dyspepsia. Gastroenterology.
110:1036–1042. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Sarnelli G, Caenepeel P, Geypens B,
Janssens J and Tack J: Symptoms associated with impaired gastric
emptying of solids and liquids in functional dyspepsia. Am J
Gastroenterol. 98:783–788. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Tack J, Piessevaux H, Coulie B, Caenepeel
P and Janssens J: Role of impaired gastric accommodation to a meal
in functional dyspepsia. Gastroenterology. 115:1346–1352. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Tack J, Caenepeel P, Fischler B,
Piessevaux H and Janssens J: Symptoms associated with
hypersensitivity to gastric distention in functional dyspepsia.
Gastroenterology. 121:526–535. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Haug TT, Svebak S, Wilhelmsen I, Berstad A
and Ursin H: Psychological factors and somatic symptoms in
functional dyspepsia. A comparison with duodenal ulcer and healthy
controls. J Psychosom Res. 38:281–291. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Talley NJ, Walker MM, Aro P, Ronkainen J,
Storskrubb T, Hindley LA, Harmsen WS, Zinsmeister AR and Agréus L:
Non-ulcer dyspepsia and duodenal eosinophilia. An adult endoscopic
population-based case-control study. Clin Gastroenterol Hepatol.
5:1175–1183. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Rothenberg ME and Cohen MB: An eosinophil
hypothesis for functional dyspepsia. Clin Gastroenterol Hepatol.
5:1147–1148. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Gargala G, Lecleire S, François A, et al:
Duodenal intraepithelial T lymphocytes in patients with functional
dyspepsia. World J Gastroenterol. 13:2333–2338. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Walker MM, Talley NJ, Prabhakar M,
Pennaneac’h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS,
Zinsmeister AR and Agreus L: Duodenal mastocytosis, eosinophilia
and intraepithelial lymphocytosis as possible disease markers in
the irritable bowel syndrome and functional dyspepsia. Aliment
Pharmacol Ther. 29:765–773. 2009. View Article : Google Scholar
|
|
17.
|
Bischoff SC: Physiological and
pathophysiological functions of intestinal mast cells. Semin
Immunopathol. 31:185–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Moayyedi P, Soo S, Deeks J, et al:
Eradication of Helicobacter pylori for non-ulcer dyspepsia.
Cochrane Database Sys Rev. 1:CD 0020962006.PubMed/NCBI
|
|
19.
|
Laine L, Schoenfeld P and Fennerty MB:
Therapy for Helicobacter pylori in patients with nonulcer
dyspepsia. A meta-analysis of randomized, controlled trials. Ann
Intern Med. 134:361–369. 2001.
|
|
20.
|
Mönkemüller K and Malfertheiner P: Drug
treatment of functional dyspepsia. World J Gastroenterol.
12:2694–2700. 2006.
|
|
21.
|
McNally MA and Talley NJ: Current
treatments in functional dyspepsia. Curr Treat Options
Gastroenterol. 10:157–168. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Mazzoleni LE, Sander GB, Francesconi CF,
et al: Helicobacter pylori eradication in functional
dyspepsia: HEROES trial. Arch Intern Med. 171:1929–1936. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
von Arnim U, Peitz U, Vinson B, Gundermann
KJ and Malfertheiner P: STW 5, a phytopharmacon for patients with
functional dyspepsia: results of a multicenter, placebo-controlled
double-blind study. Am J Gastroenterol. 102:1268–1275.
2007.PubMed/NCBI
|
|
24.
|
Tack J, Talley NJ, Camilleri M, Holtmann
G, Hu P, Malagelada JR and Stanghellini V: Functional
gastroduodenal disorders. Gastroenterology. 130:1466–1479. 2006.
View Article : Google Scholar
|
|
25.
|
Talley N, Vakil NB and Moayyedi P:
American gastroenterological association technical review on the
evaluation of dyspepsia. Gastroenterology. 129:1756–1780. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Talley NJ and Vakil N: Practice Parameters
Committee of the American College of Gastroenterology: Guidelines
for the management of dyspepsia. Am J Gastroenterol. 100:2324–2337.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Laheij RJ, van Rossum LG, Verbeek AL and
Jansen JB: Helicobacter pylori infection treatment of
nonulcer dyspepsia: an analysis of meta-analyses. J Clin
Gastroenterol. 36:315–320. 2003. View Article : Google Scholar
|
|
28.
|
de Artaza Varasa T, Valle Muñoz J,
Pérez-Grueso MJ, García Vela A, Martín Escobedo R, Rodríguez Merlo
R, Cuena Boy R and Carrobles Jiménez JM: Effect of Helicobacter
pylori eradication on patients with functional dyspepsia. Rev
Esp Enferm Dig. 100:532–539. 2008.(In Spanish).
|
|
29.
|
di Mario F, Stefani N, Bò ND, Rugge M,
Pilotto A, Cavestro GM, Cavallaro LG, Franzé A and Leandro G:
Natural course of functional dyspepsia after Helicobacter
pylori eradication: a seven-year survey. Dig Dis Sci.
50:2286–2295. 2000.PubMed/NCBI
|
|
30.
|
Lee KJ and Tack J: Duodenal implications
in the pathophysiology of functional dyspepsia. J
Neurogastroenterol Motil. 16:251–257. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Berczi L, Tamássy K, Fekete B and Kopper
L: Eosinophils and mast cells in Helicobacter pylori
infected gastric mucosa. Pathol Oncol Res. 2:229–236. 1996.
|
|
32.
|
Kikuchi T, Kato K, Ohara S, Sekine H,
Arikawa T, Suzuki T, Noguchi K, Saito M, Saito Y, Nagura H, Toyota
T and Shimosegawa T: The relationship between persistent secretion
of RANTES and residual infiltration of eosinophils and memory T
lymphocytes after Helicobacter pylori eradication. J Pathol.
192:243–250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Collen MJ and Loebenberg MJ: Basal gastric
acid secretion in nonulcer dyspepsia with or without duodenitis.
Dig Dis Sci. 34:246–250. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
George AA, Tsuchiyose M and Dooley CP:
Sensitivity of the gastric mucosa to acid and duodenal contents in
patients with nonulcer dyspepsia. Gastroenterology. 101:3–6.
1991.PubMed/NCBI
|
|
35.
|
Samsom M, Verhagen MA, vanBerge Henegouwen
GP and Smout AJ: Abnormal clearance of exogenous acid and increased
acid sensitivity of the proximal duodenum in dyspeptic patients.
Gastroenterology. 116:515–520. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
di Stefano M, Vos R, Vanuytsel T, Janssens
J and Tack J: Prolonged duodenal acid perfusion and dyspeptic
symptom occurrence in healthy volunteers. Neurogastroenterol Motil.
21:e712–e740. 2009.PubMed/NCBI
|
|
37.
|
Lee KJ, Demarchi B, Demedts I, Sifrim D,
Raeymaekers P and Tack J: A pilot study on duodenal acid exposure
and its relationship to symptoms in functional dyspepsia with
prominent nausea. Am J Gastroenterol. 99:1765–1773. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Bratten J and Jones MP: Prolonged
recording of duodenal acid exposure in patients with functional
dyspepsia and controls using a radiotelemetry pH monitoring system.
J Clin Gastroenterol. 43:527–533. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Samsom M, Verhagen MA, van Berge
Henegouwen GP and Smout AJ: Abnormal clearance of exogenous acid
and increased acid sensitivity of the proximal duodenum in
dyspeptic patients. Gastroenterology. 116:515–520. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Hongo M, Harasawa S, Mine T, Sasaki I,
Matsueda K, Kusano M, Hanyu N, Nakada K and Shibata C: Large-scale
randomized clinical study on functional dyspepsia treatment with
mosapride or teprenone: Japan Mosapride Mega-Study (JMMS). J
Gastroenterol Hepatol. 27:62–68. 2012. View Article : Google Scholar : PubMed/NCBI
|
